Results 61 to 70 of about 2,084 (194)
A New Polymeric Minimally Invasive Glaucoma Implant
A novel glaucoma implant–minimally invasive, polymeric, and potentially biodegradable–is presented. Made of a unique thermoplastic using replica molding, this device addresses common postoperative complications associated with rigid metallic implants. The potential biodegradability of the implant after implantation suggests a promising new approach for
Inês C.F. Pereira +8 more
wiley +1 more source
A review of istent inject: A novel MIGS device in India
Minimally invasive glaucoma surgery (MIGS) is a new ab-interno surgical procedure that aims to effectively and safely lower intraocular pressure (IOP) in open angle glaucoma (OAG).
Sahebaan Sethi
doaj +1 more source
Trabecular micro-bypass implant (iStent®) in a case of bilateral acute depigmentation of the iris
We report a case of bilateral acute depigmentation of the iris in which satisfactory intraocular pressure control was obtained after resolution of the acute disease with a trabecular implant (iStent®).
José Aloisio Massote (13853475) +5 more
core +1 more source
Purpose. The primary objective of this study is to evaluate the efficacy and safety profile of PreserFlo MicroShunt implantation in the medium‐ to long‐term follow‐up of patients with open‐angle glaucoma. The secondary objective is to analyze laser flare meter (LFM) values before and after PreserFlo MicroShunt implantation. Methods.
Carlo Cagini +5 more
wiley +1 more source
Pathological Mechanism and Clinical Therapy Progress of Schlemm’s Canal
Schlemm’s canal (SC) is a small circular canal in the deep part of the sclera at the junction of the sclera and cornea. As an integral component of the aqueous humor outflow, its structure and function are essential in regulating intraocular pressure (IOP).
Yasha Zhou +6 more
wiley +1 more source
Influence of Selective Laser Trabeculoplasty (SLT) on the iStent inject® outcomes
Background To evaluate the influence of Selective Laser Trabeculoplasty (SLT) on iStent inject® outcomes in open-angle glaucoma (OAG). Methods In this retrospective comparative cohort outcome study, 66 patients who were treated with two iStent inject ...
Anna-Karina B. Maier +6 more
doaj +1 more source
Glaukos iStent ® trabecular micro-bypass
The iStent trabecular micro-bypass system (Glaukos Corp. Laguna Hills, CA) was developed to address the limitations of current medical and surgical therapies for glaucoma treatment. The iStent((R)) is inserted ab interno through a small temporal clear corneal incision, bypassing the trabecular meshwork and placed in Schlemm's canal at the lower nasal ...
openaire +3 more sources
This meta-analysis explores the efficacy and adverse event profile of the iStent, an ab interno implant for the treatment of open-angle glaucoma.A systematic literature search of Ovid MEDLINE and EMBASE was used to identify peer-reviewed original studies that provided efficacy data on the first or second generation iStent for at least five eyes ...
Popovic, Marko +3 more
openaire +2 more sources
Kendall S Hunter,1 Todd Fjield,2 Hal Heitzmann,2 Robin Shandas,1 Malik Y Kahook3 1Department of Bioengineering, University of Colorado Denver, Aurora, CO, USA; 2Glaukos Corporation, Laguna Hills, CA, USA; 3University of Colorado Hospital Eye Center ...
Hunter KS +4 more
doaj
A Nonrandomized, Comparative Case Series of Combined Phacoemulsification with iStent Inject W and OMNI Surgical System [PDF]
PurposeTo compare efficacy and safety outcomes of phacoemulsification combined with either iStent inject W or OMNI surgical system with different degrees of gonioscopy-assisted transluminal trabeculotomy (GATT) in patients with glaucoma.DesignSingle ...
Pradeesh, Navanandhanan +3 more
core +1 more source

